Close
KTAR.com
News
Shows
Blogs
KTAR News on 92.3FM

Researchers: Breast cancer drug could help more patients

This undated photo provided by Daiichi Sankyo and AstraZeneca in June 2022 shows a vial and packaging for their Enhertu, an antibody-chemotherapy drug administered intravenously. (Daiichi Sankyo, AstraZeneca via AP) This undated photo provided by Daiichi Sankyo and AstraZeneca in June 2022 shows production of their Enhertu, an antibody-chemotherapy drug administered intravenously. (Daiichi Sankyo, AstraZeneca via AP) This undated photo provided by Daiichi Sankyo and AstraZeneca in June 2022 shows production of their Enhertu, an antibody-chemotherapy drug administered intravenously. (Daiichi Sankyo, AstraZeneca via AP) This undated photo provided by Daiichi Sankyo and AstraZeneca in June 2022 shows a vial and packaging for their Enhertu, an antibody-chemotherapy drug administered intravenously. (Daiichi Sankyo, AstraZeneca via AP)